Amneal Pharmaceuticals/AMRX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Amneal Pharmaceuticals

Amneal Pharmaceuticals, Inc., is a fully integrated global essential medicine company. The Company is engaged in the development, manufacturing, and distribution of a diverse portfolio of approximately 270 pharmaceutical products, primarily within the United States. The Company’s Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermal across a broad range of therapeutic categories. The Company's Specialty segment’s portfolio includes central nervous system disorders (Parkinson’s disease, spasticity, migraine), endocrinology (hypothyroidism), and other therapeutic areas. The Company’s AvKARE segment provides pharmaceuticals, medical and surgical products, and services to government, retail, and institutional markets.

Ticker

AMRX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

J. Kevin Buchi

Employees

7,700

Headquarters

Bridgewater, United States
Website
amneal.com

AMRX Metrics

BasicAdvanced
$2.1B
Market cap
-
P/E ratio
-$0.56
EPS
1.19
Beta
-
Dividend rate
$2.1B
1.19253
$6.98
$2.29
1.6M
1.654
0.97
162.569
1.27%
-3.40%
-146.25%
-4.27%
0.826
16.595
9.82%
36.75%
6.30%

What the Analysts think about AMRX

Analyst Ratings

Majority rating from 6 analysts.
Buy

AMRX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-13.89% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$659M
6.84%
Net income
-$92M
-7.10%
Profit margin
-13.89%
-13.08%

AMRX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 52.17%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.19
$0.19
$0.14
$0.14
-
Expected
$0.11
$0.13
$0.09
$0.09
$0.14
Surprise
79.25%
49.84%
55.21%
52.17%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Amneal Pharmaceuticals stock?

Amneal Pharmaceuticals (AMRX) has a market cap of $2.1B as of June 17, 2024.

What is the P/E ratio for Amneal Pharmaceuticals stock?

The price to earnings (P/E) ratio for Amneal Pharmaceuticals (AMRX) stock is 0 as of June 17, 2024.

Does Amneal Pharmaceuticals stock pay dividends?

No, Amneal Pharmaceuticals (AMRX) stock does not pay dividends to its shareholders as of June 17, 2024.

When is the next Amneal Pharmaceuticals dividend payment date?

Amneal Pharmaceuticals (AMRX) stock does not pay dividends to its shareholders.

What is the beta indicator for Amneal Pharmaceuticals?

Amneal Pharmaceuticals (AMRX) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Amneal Pharmaceuticals stock price target?

The target price for Amneal Pharmaceuticals (AMRX) stock is $8, which is NaN% below the current price of $. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Amneal Pharmaceuticals stock

Buy or sell Amneal Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing